2022
DOI: 10.1016/j.aace.2022.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Voriconazole-Induced Diffuse Periostitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The authors discovered 26 articles, all of which reported periostitis after duration of treatment that ranged from 6 weeks to 8 years [11] . Since 2016, additional case reports on this have been published [12 , 13] . In addition, iatrogenic causes of perositis have been reported among neonatal patients.…”
Section: Discussionmentioning
confidence: 99%
“…The authors discovered 26 articles, all of which reported periostitis after duration of treatment that ranged from 6 weeks to 8 years [11] . Since 2016, additional case reports on this have been published [12 , 13] . In addition, iatrogenic causes of perositis have been reported among neonatal patients.…”
Section: Discussionmentioning
confidence: 99%
“…7 On Bone and Minerals, authors report an interesting case of diffuse periostitis due to the antifungal (Voriconazole) use leading to skeletal fluorosis, which can lead to diffuse bone pain. 8 Another interesting case reported on familial hypocalciuric hypercalcemia (FHH) with multiple family members due to calcium-sensing receptor gene (CASR) sequence variant [missense CASR in exon 3 c.392C>A (p.Ala110Asp)], currently listed under variant of unknow significance (VUS). This case suggests this CASR variant is pathogenic causing FHH.…”
mentioning
confidence: 99%